Clinical Trial Update: The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus [NA]

View source ↗

Summary

Completed clinical trial evaluating the impact of subcutaneous glucagon before, during, and after exercise in patients with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED